Sabine Kathrin Mai

Summary

Affiliation: University of Heidelberg
Country: Germany

Publications

  1. ncbi Radiochemotherapy for anal carcinoma - effectivity and late toxicity
    S K Mai
    Sektion Strahlentherapie, Institut fur Klinische Radiologie, Universitatsklinikum Mannheim, Germany
    Onkologie 25:55-9. 2002
  2. ncbi Solitary bone metastasis from myxoid liposarcoma
    S K Mai
    Sektion Strahlentherapie, Universitatsklinikum Mannheim, Germany
    Onkologie 26:341-3. 2003
  3. ncbi The influence of smoking and other risk factors on the outcome after radiochemotherapy for anal cancer
    Sabine Kathrin Mai
    Department of Radiation Oncology of the University Medical Center Mannheim, Germany
    Radiat Oncol 2:30. 2007
  4. ncbi Long-term outcome after combined radiochemotherapy for anal cancer - retrospective analysis of efficacy, prognostic factors, and toxicity
    Sabine K Mai
    Department of Radiation Oncology, University Medical Center Mannheim, Germany
    Onkologie 31:251-7. 2008
  5. ncbi Can the radiation dose to CT-enlarged but FDG-PET-negative inguinal lymph nodes in anal cancer be reduced?
    Sabine Kathrin Mai
    Department of Radiation Oncology, University Medical Center Mannheim, University of Heidelberg, Germany
    Strahlenther Onkol 185:254-9. 2009
  6. ncbi Quality of life outcomes in patients with anal cancer after combined radiochemotherapy
    Grit Welzel
    Department of Radiation Oncology, University Medical Center Mannheim, University of Heidelberg, Germany
    Strahlenther Onkol 187:175-82. 2011
  7. ncbi Reduced rectal toxicity with ultrasound-based image guided radiotherapy using BAT (B-mode acquisition and targeting system) for prostate cancer
    Markus Bohrer
    Department of Radiation Oncology, University Medical Center, Theodor Kutzer Ufer, 68167, Mannheim, Germany
    Strahlenther Onkol 184:674-8. 2008

Detail Information

Publications7

  1. ncbi Radiochemotherapy for anal carcinoma - effectivity and late toxicity
    S K Mai
    Sektion Strahlentherapie, Institut fur Klinische Radiologie, Universitatsklinikum Mannheim, Germany
    Onkologie 25:55-9. 2002
    ..Radiochemotherapy of anal carcinoma is an organ-sparing approach with a high curative potential. The purpose was to evaluate the effectivity and late toxicity for patients treated with radiochemotherapy in our department...
  2. ncbi Solitary bone metastasis from myxoid liposarcoma
    S K Mai
    Sektion Strahlentherapie, Universitatsklinikum Mannheim, Germany
    Onkologie 26:341-3. 2003
    ..Extrapulmonary metastasis is more common in liposarcoma than in other soft tissue sarcomas. However, osseous metastases are rare...
  3. ncbi The influence of smoking and other risk factors on the outcome after radiochemotherapy for anal cancer
    Sabine Kathrin Mai
    Department of Radiation Oncology of the University Medical Center Mannheim, Germany
    Radiat Oncol 2:30. 2007
    ..Smoking during radiochemotherapy therapy may have a negative influence on prognosis. We evaluated the effect of smoking during radiochemotherapy on the outcome for patients with anal cancer...
  4. ncbi Long-term outcome after combined radiochemotherapy for anal cancer - retrospective analysis of efficacy, prognostic factors, and toxicity
    Sabine K Mai
    Department of Radiation Oncology, University Medical Center Mannheim, Germany
    Onkologie 31:251-7. 2008
    ..This retrospective study evaluated the efficacy, prognostic factors, and toxicity of combined radiochemotherapy for anal cancer...
  5. ncbi Can the radiation dose to CT-enlarged but FDG-PET-negative inguinal lymph nodes in anal cancer be reduced?
    Sabine Kathrin Mai
    Department of Radiation Oncology, University Medical Center Mannheim, University of Heidelberg, Germany
    Strahlenther Onkol 185:254-9. 2009
    ..To investigate whether a dose reduction to CT-enlarged but FDG-PET-negative (([(18)F]-fluoro-2-deoxy-D-glucose positron emission tomography) inguinal lymph nodes in radiochemotherapy of anal cancer is safe...
  6. ncbi Quality of life outcomes in patients with anal cancer after combined radiochemotherapy
    Grit Welzel
    Department of Radiation Oncology, University Medical Center Mannheim, University of Heidelberg, Germany
    Strahlenther Onkol 187:175-82. 2011
    ..To assess self-reported quality of life (QoL) experienced by anal cancer patients after radiochemotherapy, and to identify patient- and disease-related factors associated with QoL...
  7. ncbi Reduced rectal toxicity with ultrasound-based image guided radiotherapy using BAT (B-mode acquisition and targeting system) for prostate cancer
    Markus Bohrer
    Department of Radiation Oncology, University Medical Center, Theodor Kutzer Ufer, 68167, Mannheim, Germany
    Strahlenther Onkol 184:674-8. 2008
    ..To evaluate the effect of image guided radiotherapy with stereotactic ultrasound BAT (B-mode acquisition and targeting system) on rectal toxicity in conformal radiotherapy of prostate cancer...